GARS1 and cancer: Figure 5 demonstrates a significant association between GARS1 expression and immune subtypes in 16 specific cancers, including ACC, BLCA, BRCA, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, PAAD, PRAD, SARC, STAD, TGCT, THCA, and UCEC (P<0.05).